HRA005229
Title:
Neo-antigen Discovery of Cancer Immunotherapy
Release date:
2023-10-30
Description:
Tumor-specific antigens (TSAs) are highly desirable targets for cancer immunotherapy. However, current clinical studies have predominantly focused on neoantigens present in exon regions, while the limited number of TSAs identified from coding regions has impeded the development and application of immunotherapy. Here, we developed a proteogenomic approach that integrates multi-omics data from the whole genome, transcriptome, and immunopeptidome to globally discover TSAs.
Data Accessibility:   
Controlled access Request Data
BioProject:
Study type:
Disease Study
Disease name:
colon cancer
Data Access Committee

For each controlled access study, there is a corresponding Data Access Committee(DAC) to determine the access permissions. Access to actual data files is not managed by NGDC.


DAC NO.:
DAC name:
DAC of CRC
Contact person:
DONG Xuan
Email:
dongxuan@genomics.cn
Description:
In charge of data access of CRC NGS data.
Individuals & samples
Submitter:   DONG Xuan / dongxuan@genomics.cn
Organization:   BGI
Submission date:   2023-08-03
Requests:   3